XML 57 R44.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stockholders' Equity (Details)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
USD ($)
$ / shares
shares
Jun. 30, 2024
USD ($)
$ / shares
shares
Stockholders Equity [Line Items]    
Outstanding stock warrants | shares   4,904,016
Weighted average exercise price for exercisable | $ / shares $ 11.07 $ 11.07
Equity plans description   Under the 2018 Equity Plan, the number of shares issuable under the Plan on the first day of each fiscal year increase by an amount equal to the lower of (i) 100,000 shares (after a later 10 for 1 stock split) or (ii) 5% of the outstanding shares on the last day of the immediately preceding fiscal year.  At the Company’s annual meeting on May 17, 2023, the stockholders approved an amendment to the 2021 Equity Plan that, amongst other things, increased the number of the shares available under the 2021 Equity Plan to 10,000,000 shares, and the shares available under the 2021 Equity Plan increased by 1,000,000 shares on January 1, 2024 to 11,000,000. Upon review of the previously granted shares in previous years and the availability of shares, on April 9, 2024, the Board of Directors approved the 2024 Omnibus Equity Plan (the “2024 Plan”) which will provide an initial 10,000,000 shares of common stock available for grant per the terms of the 2024 Plan and provides alignment with long-term stockholder value creation. The 2024 Omnibus Equity Plan was approved by the stockholders at the Company’s annual general meeting held on June 12, 2024.
Aggregate shares | shares 15,000,000  
shares based compensation | $   $ 5,950
Stock based compensation surrendered shares. | $   $ 930
Restricted Stock Awards [Member]    
Stockholders Equity [Line Items]    
Outstanding restricted stock | shares   873,772
Weighted average remaining contractual life (in years)   6 years 10 months 28 days
Unrecognized compensation cost | $ $ 2,030 $ 2,030
Performance-based awards [Member]    
Stockholders Equity [Line Items]    
Unrecognized compensation cost | $ $ 360 $ 360
Common Stock [Member]    
Stockholders Equity [Line Items]    
Weighted average remaining contractual life (in years)   3 years 1 month 24 days
Common Stock [Member]    
Stockholders Equity [Line Items]    
Additional shares | shares 5,000,000 5,000,000